J.P. Morgan Exchange-Traded Fund Trust - JPMorgan Active Developing Markets Equity ETF (JADE) Stock Price

78.5496 ▲ +0.103 (+0.13%)
Open: 78.41 Vol: 2.69K Day's range: 78.37 - 78.5496 Jun 12, 16:00 EDT
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
JADE Technical Analysis
5 mins 30 mins Hourly Daily Weekly
BUY BUY BUY BUY BUY
  5 mins 30 mins Hourly Daily Weekly
MA5 77.23▲ 77.23▲ 77.25▲ 76.97▲ 76.89▲
MA10 77.27▲ 77.26▲ 77.67▲ 78.32▲ 75.64▲
MA20 77.82▲ 77.56▲ 77.38▲ 77.68▲ 72.04▲
MA50 72.63▲ 72.82▲ 72.73▲ 75.22▲ 64.87▲
MA100 71.64▲ 70.32▲ 69.56▲ 72.09▲ 56.72▲
MA200 N/A     N/A     N/A     66.96▲ N/A    
  5 mins 30 mins Hourly Daily Weekly
MACD -0.386▼ -0.334▼ -0.338▼ -0.354▼ 0.336▲
RSI 61.289▲ 61.450▲ 61.214▲ 54.889▲ 64.580▲
STOCH 34.171     34.171     23.589     27.787     80.234▲
WILL %R -52.533     -52.533     -52.533     -43.459     -17.540▲
CCI 7.901     7.901     -0.555     -4.541     73.139    
Latest Filters Detected On JADE
RSI $JADE RSI(14) Crossed Above 50 Set Alert
MA $JADE Price Crossed Above MA(26) Set Alert
MA $JADE Price Crossed Above MA(7) Set Alert
CDL $JADE Marubozu Candlestick Pattern Detected Set Alert
J.P. Morgan Exchange-Traded Fund Trust - JPMorgan Active Developing Markets Equity ETF News
Jade Biosciences Announces Closing of Public Offering of Common Stock, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
Friday, June 05, 2026 01:15 PM
SAN FRANCISCO and VANCOUVER, British Columbia, June 05, 2026 (GLOBE NEWSWIRE) -- Jade Biosciences, Inc. (“Jade” or the “Company”) (Nasdaq: JBIO), a clinical-stage biotechnology company focused on ...
Jade Biosciences: Strong Early Signal, But Still A Wait For Proof
Tuesday, June 02, 2026 04:30 AM
Jade Biosciences’ JADE101 Phase 1 IgA biomarker win hints at 12-week dosing, but valuation, funding, and Phase 2 2027 risks persist. Learn more about JBIO stock here.
Jade Biosciences' JADE101 delivers deep IgA cuts, clearing path for kidney trials
Monday, June 01, 2026 06:07 PM
Jade Biosciences (NASDAQ:JBIO) said interim results from a Phase 1 healthy volunteer study of JADE101 showed rapid and durable reductions in serum IgA, supporting the company's plan to advance the ...
JADE historical stock data
date open high low close volume
12/06/26 78.41 78.5496 78.37 78.5496 2,685
11/06/26 76.34 78.4466 76.34 78.4466 2,634
10/06/26 76.12 77.08 75.2412 75.2412 1,594
09/06/26 77.145 77.145 74.49 76.3033 17,038
08/06/26 76.52 76.52 76.20 76.3288 1,306
05/06/26 76.95 77.11 75.0466 75.0466 5,730
04/06/26 79.84 80.0658 79.84 80.0658 3,104
03/06/26 80.66 80.6891 80.585 80.6891 2,581
02/06/26 80.93 81.6699 80.93 81.6561 1,498
01/06/26 80.61 81.03 80.60 80.8611 4,202
Quote Details
52wk Low:52.499
52wk High:81.67
Vol:2.69K
Avg Vol(3m):38.2K
1Y Chng:+45.15%
1M Chng:+5.54%
Add to Watch List
More Information
Sector N/A
Index N/A
Market Cap. 0.00